Table 1.
nox member | localization | ROS type | regulators | expression | activation | cardiovascular physiology | cardiovascular pathophysiology |
---|---|---|---|---|---|---|---|
Nox1 | transmenbrane caveolae endosomes |
superoxide anion | p22phox p47phox, Noxa1, Rac or Noxo1, Noxa1, Rac |
smooth muscle cells epithelial cells, uterus osteoclasts, neurons |
stimulus induced Ang II, PDGF, FGF |
proliferation, migration extracellular matrix production host defense |
vascular hypertrophy hypertension, vascular injury diabetes |
Nox2 | phagosomes caveolae endosomes |
superoxide anion | p22phox, p47phox, p67phox, p40phox rac |
endothelial cells cardiomyocytes, hepatocytes fibroblastes, phagocytes neurons, skeletal muscle myocytes |
agonist-induced (Ang II, VEGF, TNFα, endothelin1) mechanical forces |
angiogenesis apoptosis, oxygen sensing inflammation |
hypoxia, diabetes hypercholesterolemia pulmonary hypertension |
Nox3 | plasma membrane | superoxide anion | p22phox, Noxo1 possibly Noxa1, Rac |
inner ear lung endothelial cells hepatocytes |
agonist-induced (TNFα) constitutively active |
unknown | insulin resistance |
Nox4 | focal adhesion nucleus endoplasmic reticulum |
hydrogen peroxide | p22phox Poldip2 |
mesangial cells, smooth muscle endothelial cells, fibroblasts keratinocytes, osteoclasts neurons, hepatocytes cardiomyocytes |
constitutively active stimulus induced (TGFβ, IL-1, Vit.D, thrombin, ER stressors) |
senescence, apoptosis endoplasmic reticulum stress survival, differentiation oxygen sensing cytoskeletal regulation |
hypertrophy pulmonary hypertension/fibrosis metabolic syndrome |
Nox5 | internal membranes plasma membrane |
superoxide | calcium | endothelial cells smooth muscle cells testes, spleen |
calcium activated | proliferation inflammation |
unknown |